A large pharma needed to launch a three-part global Phase 2/3 sickle cell disease trial but faced tight timelines and limited resources. IQVIA deployed its eCOA platform to design, configure, and test 11 electronic assessments within eight weeks. Leveraging its pre-approved eCOA library and streamlined translation process, setup was accelerated by 50%. Strong project management, open collaboration, and rapid validation ensured FDA compliance and timely delivery. Results included meeting the First Patient In milestone on schedule, eliminating quality issues, and delivering assessments two days ahead of deadline, enabling smooth trial execution.

Join for free to read